Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.33
Delayed Data
As of Apr 27
 +0.11 / +3.42%
Today’s Change
2.35
Today|||52-Week Range
6.36
+20.65%
Year-to-Date
No recent news for Cardiome Pharma Corp.

Today’s Trading

Previous close3.22
Today’s open3.24
Day’s range3.22 - 3.40
Volume158,663
Average volume (3 months)63,622
Market cap$106.2M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)+41.79%
Earnings growth (this year)+32.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+20.78%
P/E ratio--
Price/Sales2.80
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.04-1.87%
ORMPOramed Pharmaceutica...-0.40-4.78%
SRNESorrento Therapeutic...+0.10+5.00%
ARLZAralez Pharmaceutica...-0.06-3.55%
Data as of 04/27/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$25.3M
Annual profit (last year)-$19.6M
Net profit margin-77.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts